Chan Kim
Chonnam National University(KR)Yonsei University(KR)CHA University Bundang Medical Center(KR)CHA University(KR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Spine and Intervertebral Disc Pathology, Colorectal Cancer Treatments and Studies, Ferroptosis and cancer prognosis
Most-Cited Works
- → Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity(2020)620 cited
- → Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment(2016)315 cited
- → STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade(2019)297 cited
- → Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis(2016)206 cited
- → Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma(2020)187 cited
- → Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial